Related Experiment Video

Updated: Jul 29, 2026

Intra-Arterial Delivery of Neural Stem Cells to the Rat and Mouse Brain: Application to Cerebral Ischemia
14:53

Intra-Arterial Delivery of Neural Stem Cells to the Rat and Mouse Brain: Application to Cerebral Ischemia

Published on: June 26, 2020

9.9K

[American Academy of Neurology, Philadelphia, 26 April-3 May, 2014]

F Durif1, I Sibon1, B de Toffol1

  • 1Hôpital de la Salpêtrière, bâtiment Babinski, consultation de pathologie neuro-musculaire, 47, boulevard de l'Hôpital, 75651 Paris cedex 13, France.

Revue Neurologique
|June 2, 2014
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Author Spotlight: A Novel Approach to Cerebral Ischemia Modeling – Enhancing Reperfusion and Simplifying Procedure
04:18

Author Spotlight: A Novel Approach to Cerebral Ischemia Modeling – Enhancing Reperfusion and Simplifying Procedure

Published on: May 31, 2024

2.3K
Visualizing the Gatekeeper: Evan's Blue Dye-Based Assessment of Blood-Brain Barrier Permeability in Adult Zebrafish
06:49

Visualizing the Gatekeeper: Evan's Blue Dye-Based Assessment of Blood-Brain Barrier Permeability in Adult Zebrafish

Published on: September 30, 2025

1.1K

Related Experiment Videos

Last Updated: Jul 29, 2026

Intra-Arterial Delivery of Neural Stem Cells to the Rat and Mouse Brain: Application to Cerebral Ischemia
14:53

Intra-Arterial Delivery of Neural Stem Cells to the Rat and Mouse Brain: Application to Cerebral Ischemia

Published on: June 26, 2020

9.9K
Author Spotlight: A Novel Approach to Cerebral Ischemia Modeling – Enhancing Reperfusion and Simplifying Procedure
04:18

Author Spotlight: A Novel Approach to Cerebral Ischemia Modeling – Enhancing Reperfusion and Simplifying Procedure

Published on: May 31, 2024

2.3K
Visualizing the Gatekeeper: Evan's Blue Dye-Based Assessment of Blood-Brain Barrier Permeability in Adult Zebrafish
06:49

Visualizing the Gatekeeper: Evan's Blue Dye-Based Assessment of Blood-Brain Barrier Permeability in Adult Zebrafish

Published on: September 30, 2025

1.1K

Related Concept Videos

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

Articles linked to this work by shared authors, journal, and citation graph.

Geographic disparities in MRI features of ischemic stroke and small vessel disease: A comparative study between French Guiana and mainland France. Findings from the BECATOUR multicenter registry.

Revue neurologique·2026

Continuous subcutaneous perfusion of apomorphine in Parkinson's disease: Towards monotherapy?

Revue neurologique·2026

Retrospective, descriptive study of acute myelitis in French Guyana.

Revue neurologique·2025

The pattern of cortical thickness associated with executive dysfunction in MCI and SCC: The MEMENTO cohort.

Revue neurologique·2024

Epilepsy and psychosis.

Revue neurologique·2024

Medical demography at stroke centers: Current situation in France.

Revue neurologique·2023

Prognostic value of stroke etiology following bridging therapy with tenecteplase: A TETRIS analysis.

Revue neurologique·2026

Starting from the syndrome: A comprehensive review on mononeuropathy multiplex.

Revue neurologique·2026

French guidelines for the diagnosis and management of neuromyelitis optica spectrum disorder.

Revue neurologique·2026

French guidelines for post-polio syndrome and management of effects of aging in people with sequelae of acute anterior poliomyelitis.

Revue neurologique·2026

A multi-outcome prognostic score for therapeutic responses in multiple sclerosis.

Revue neurologique·2026

Real-world assessment of effectiveness and safety of candesartan in migraine prevention: Results of the French FHU InovPain registry.

Revue neurologique·2026

Integrated Plasma Proteomics and Metabolomes Reveal Potential Biomolecules Linking PM2.5 to Depression.

Environmental toxicology and pharmacology·2026

The oxytocinergic system in functional neurological disorder: Preliminary testing of associations with interoception and childhood trauma.

Comprehensive psychoneuroendocrinology·2026

Parabrachial oxytocin receptor-expressing neurons link social observation of distress to defensive behavior.

bioRxiv : the preprint server for biology·2026

Mapping the behavioral-affective network of physical activity and aggressive behavior among adolescents: a network and Bayesian graph analysis.

Frontiers in psychology·2026

Association of total and brain-derived Alzheimer's disease plasma biomarkers with brain amyloid deposition in a community-based sample.

medRxiv : the preprint server for health sciences·2026

Characterization of nucleus accumbens dopamine dynamics during positive and negative operant reinforcement in rats.

bioRxiv : the preprint server for biology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us